These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.
Ever since the first hamburger grown from bovine stem cells was unveiled in 2013, with a €250,000 price tag (around $280,000), biotechnologists have raced to produce an affordable alternative that tastes the same as meat, no slaughter—and fewer emissions—required. Startup Good Meat surged ahead when it launched its bioreactor-cultivated chicken morsels in Singapore in 2020, but rival Upside Foods wasn’t far behind. On June 21, the U.S. Department of Agriculture authorized both companies to sell cultivated meat in the U.S. Now that they are no longer vying for first, the companies can compete on taste and price.
More Must-Reads from TIME
- Donald Trump Is TIME's 2024 Person of the Year
- Why We Chose Trump as Person of the Year
- Is Intermittent Fasting Good or Bad for You?
- The 100 Must-Read Books of 2024
- The 20 Best Christmas TV Episodes
- Column: If Optimism Feels Ridiculous Now, Try Hope
- The Future of Climate Action Is Trade Policy
- Merle Bombardieri Is Helping People Make the Baby Decision
